Showing 1 - 4 results of 4 for search 'Hossein Panjideh', query time: 0.02s Refine Results
  1. 1
    Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins</i> 2022, <i>14</i>, 478

    Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. <i>Toxins<... by Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861

    Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861 by Hossein Panjideh, Nicole Niesler, Alexander Weng, Hendrik Fuchs

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies

    Glycosylated Triterpenoids as Endosomal Escape Enhancers in Targeted Tumor Therapies by Hendrik Fuchs, Nicole Niesler, Alexandra Trautner, Simko Sama, Gerold Jerz, Hossein Panjideh, Alexander Weng

    Published 2017-03-01
    Get full text
    Article
  4. 4
    Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5

    Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5 by Frank Breitling, Gerhard Moldenhauer, Antonio Pezzutto, Oliver Schmetzer, Martin Lipp, Saskia Meyer, Regina Fertig, Hossein Panjideh, Dorothée Deppe, Sandra Lüttgau

    Published 2013-05-01
    Get full text
    Article

Search Tools: